 In 2016 after treatment that included miltefosine, another child became the fourth person in the United States to survive "Naegleria fowleri" infection.Miltefosine is commercially available in the United States through Profounda.Previously one could only get it from the CDC for emergency use under an expanded access IND protocol for treatment of free-living amoeba (FLA) infections